Two Sigma Advisers’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-136,400
Closed -$6.88M 2619
2023
Q2
$6.88M Sell
136,400
-94,600
-41% -$5.03M 0.02% 628
2023
Q1
$12.6M Sell
231,000
-21,500
-9% -$1.26M 0.03% 474
2022
Q4
$15.8M Buy
252,500
+97,200
+63% +$6.45M 0.04% 399
2022
Q3
$10.9M Buy
155,300
+145,200
+1,438% +$10M 0.03% 479
2022
Q2
$572K Buy
10,100
+2,900
+40% +$159K ﹤0.01% 1850
2022
Q1
$451K Buy
+7,200
New +$388K ﹤0.01% 2038
2021
Q3
Sell
-3,600
Closed -$228K 2727
2021
Q2
$228K Sell
3,600
-37,200
-91% -$2.2M ﹤0.01% 2236
2021
Q1
$2.44M Buy
+40,800
New +$2.22M 0.01% 1174

Other funds holding AXNX

Two Sigma Advisers's AXNX Position: Q3 2023 in Review

Two Sigma Advisers sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 136,400 shares — an estimated $6.88M sold.

Two Sigma Advisers first reported a position in AXNX in Q1 2021 and held it in 8 quarters. The position peaked at $15.8M in Q4 2022. 220 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • Two Sigma Advisers reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 136,400 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $6.88M.
  • Two Sigma Advisers first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Two Sigma Advisers's Axonics, Inc. Common Stock position peaked at $15.8M in Q4 2022.
  • 220 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.